MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
1.500
+0.020 (1.35%)
At close: Sep 17, 2025, 4:00 PM EDT
1.520
+0.020 (1.33%)
After-hours: Sep 17, 2025, 7:03 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Cell Therapy
22.83M
Log In
Log In
Log In
Log In
Upgrade
Cell Therapy Growth
-25.26%
Log In
Log In
Log In
Log In
Upgrade
Program-related
11.47M
Log In
Log In
Log In
Log In
Upgrade
Program-related Growth
148.38%
Log In
Log In
Log In
Log In
Upgrade
Drug Discovery
6.99M
Log In
Log In
Log In
Log In
Upgrade
Drug Discovery Growth
-23.14%
Log In
Log In
Log In
Log In
Upgrade
Leased Elements
-
Log In
Log In
Log In
Log In
Upgrade
Leased Elements Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
41.29M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-6.72%
Log In
Log In
Log In
Log In
Upgrade